There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for Jaguar Health Inc. (JAGX) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.001, or -0.14%, to $0.719. The Jaguar Health Inc. has recorded 36,496 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Jaguar Health Launches AI-powered Web Portal to Support Patient Access to Mytesi, the Company’s FDA-approved Prescription Drug.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $0.72 and fluctuated between $0.9349 as its day high and $0.6410 as its day low. The current market capitalization of Jaguar Health Inc. is $8.32M. A total of 8.58 million shares were traded on the day, compared to an average of 2.02M shares.
Insider trades can also provide insight into a stock’s future direction. During the recent three months, JAGX has seen 5 BUY and 0 SELL insider trades, representing the acquisition of 969 and the disposition of 0 shares. Over the last 12 months, there were 10 BUYs and 0 SELLs from insiders. Insiders purchased 50,818 shares during that period but sold 0.
In the most recent transaction, Wolin Jonathan S. bought 317 shares of JAGX for 0.03 per share on Dec 31. After the transaction, the Chief of Staff, CCO & GC now owns 6,983 company shares.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for JAGX in the last 3 months, the mean price target is $150.00 with high estimates of $150.00 and low estimates of $150.00. In terms of 52-week highs and lows, JAGX has a high of $32.70 and a low of $0.46.
As of this writing, JAGX has an earnings estimate of $0 per share for the current quarter. EPS was calculated based on a consensus of 0 estimates, with a high estimate of $0 per share and a lower estimate of $0. The company reported an EPS of -$9 in the last quarter, which was 45.50% higher than expectations of -$16.5.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. JAGX’s latest balance sheet shows that the firm has $17.05M in Cash & Short Term Investments as of fiscal 2021. There were $29.36M in debt and $15.47M in liabilities at the time. Its Book Value Per Share was -$0.33, while its Total Shareholder’s Equity was $11.85M.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for JAGX is Buy with a score of 5.00.